Panacos Pharmaceuticals, Inc. (PANC) Research

Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm specializing in the research and development of orally administered small-molecule therapeutics. These innovative drugs are crafted to combat human immunodeficiency virus (HIV) and various other viral diseases affecting humans. The company's scientific methodology concentrates on identifying novel targets within the viral life cycle, specifically focusing on processes like virus maturation and fusion. Currently, their product portfolio includes advanced initiatives, such as second- and third-generation programs, centered on inhibiting HIV maturation. Founded in 1999, the company's main operations are situated in Watertown, Massachusetts.

Market snapshot

Symbol
PANC
Price
$0.00
Day change
0.00%
Market cap
$5.4K
P/E ratio
-0.00x
52-week range
0.000001-0.0001
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Arno Therapeutics, Inc. (ARNI)
  • Better Therapeutics, Inc. (BTTX)
  • Baudax Bio, Inc. (BXRXQ)
  • Calithera Biosciences, Inc. (CALA)
  • Innovation1 Biotech Inc. (IVBT)
  • Inyx, Inc. (IYXI)
  • Kaleido Biosciences, Inc. (KLDO)
  • Oncology Pharma Inc. (ONPH)

Recent insider activity

  • Fischer Laurent — A-Award (15000 shares) on 2008-06-19
  • LERNER IRWIN — A-Award (15000 shares) on 2008-06-19
  • FLETCHER R JOHN — A-Award (15000 shares) on 2008-06-19
  • Savage Robert G. — A-Award (15000 shares) on 2008-06-19
  • LIMBER JOSEPH M — A-Award (15000 shares) on 2008-06-19

Open Panacos Pharmaceuticals, Inc. (PANC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.